Article info
PDFOriginal article
KRAS fluorescence in situ hybridisation testing for the detection and diagnosis of pancreatic adenocarcinoma
- Correspondence to Dr Noriyuki Shiroma, Department of Anatomical Pathology, Hiroshima University Hospital, Hiroshima 734-8551, Japan; nshiroma{at}hiroshima-u.ac.jp
Citation
KRAS fluorescence in situ hybridisation testing for the detection and diagnosis of pancreatic adenocarcinoma
Publication history
- Received February 4, 2018
- Revised April 4, 2018
- Accepted April 5, 2018
- First published April 25, 2018.
Online issue publication
July 10, 2020
Article Versions
- Previous version (19 September 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.